News - Tarceva, Astellas Pharma


Current filters:

TarcevaAstellas Pharma

Popular Filters

Regulatory briefs from Ipsen/Inspiration, Janssen and Astellas


French drugmaker Ipsen (Euronext: IPN) and partner USA-based privately-held Inspiration Biopharmaceuticals…

Astellas PharmaBiotechnologyEuropeInspiration BiopharmaceuticalsIpsenJanssen-CilagJohnson & JohnsonNorth AmericaOBI-1OncologyPharmaceuticalRegulationTarcevaZytiga

Adding Tarceva to Nexavar no better than Nexavar alone for liver cancer


A Phase III trial evaluating the efficacy and safety of the addition of Roche's Tarceva (erlotinib) tablets…

Astellas PharmaBayerNexavarOncologyOnyx PharmaceuticalsPharmaceuticalResearchTarceva

Back to top